New drug trial aims to stop Alzheimer's before it starts
Prevention
Not yet recruiting
This study is testing whether an investigational drug called HT-4253 can prevent Alzheimer's disease in people who carry a specific genetic risk factor (APOE4) and show early signs of brain changes. About 112 participants, aged 50-75 and without an Alzheimer's diagnosis, will rec…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated Mar 10, 2026 12:54 UTC